Panacea Biotec files patent infringement suit against Sanofi Healthcare

[{"selector":"#anim-0ee9ae86-f788-44c5-ae0d-4631eac77281","keyframes":{"transform":["translate3d(0px, 100%, 0)","translate3d(0px, 0px, 0)"]},"delay":350,"direction":"normal","duration":600,"easing":"cubic-bezier(0.445, 0.05, 0.55, 0.95)","fill":"both"}] Panacea Biotec files patent infringement suit against Sanofi Healthcare

[{"selector":"#anim-7abbc394-741b-4b4f-9886-13d5af403b6b","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-1e8ae6ad-cc49-4c70-8943-0694b8b7db75","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-914a77d0-be15-4746-8e73-dedd8ee2b650","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] NEWS Panacea Biotec files patent infringement suit against Sanofi Healthcare By Pallavi Paul Panacea Biotec Limited filed an injunction application against Sanofi Healthcare India Private Limited for infringing its registered patent in the Delhi High Court. The plaintiff had been granted patent titled ‘ Novel Combination Vaccines with Whole Cell Pertussis and Method of Manufacturing the Same’ dated 30/03/2016 under number IN 272351 for a particular pediatric vaccine. The plaintiff contended that the defendant was granted permission to manufacture and market that vaccine subject to condition that the

[{"selector":"#anim-85899c5b-875d-45d2-b231-59d457891694","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-bf7c4476-58ed-445a-bf10-b76a2f4af628","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-b6e04618-e6c8-41c2-a5a4-78b2f10cdded","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] NEWS By Pallavi Paul defendant should continue the ongoing study on booster dose and safely submit the efficacy data as and when required. After some arguments, the defendant submitted that they will not manufacture/market the vaccine that infringes the amended claim of the plaintiff. The matter is listed for hearing again on 07.09.2021.